deltatrials
Terminated PHASE3 INTERVENTIONAL 4-arm NCT02929589

Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy

Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy: A Prospective, Placebo-Controlled, Double-Blind, Randomized Controlled Trial

Sponsor: Mike O'Callaghan Military Hospital

Conditions Hernia Pain
Interventions Ibuprofen Ibuprofen + Opioid medication Opioid Medication Placebo
Updated 12 times since 2017 Last updated: Mar 25, 2024 Started: Jul 5, 2018 Primary completion: Aug 23, 2021 Completion: Aug 23, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The use of robotic surgery made this study obsolete.

Other terminated trials from Mike O'Callaghan Military Hospital

See all terminations from Mike O'Callaghan Military Hospital

Other Hernia trials with similar outcome

Browse all Hernia trials

Listed as NCT02929589, this PHASE3 trial focuses on Hernia and Pain and remains terminated or withdrawn. Sponsored by Mike O'Callaghan Military Hospital, it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotNot Yet Recruiting~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshotNot Yet Recruiting~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotNot Yet Recruiting~Dec 2018 – ~Sep 2020 · 21 months · monthly snapshotRecruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotSuspended~Jan 2021 – ~Feb 2022 · 13 months · monthly snapshotSuspended~Feb 2022 – ~Apr 2024 · 26 months · monthly snapshotTerminated~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Apr 2024 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Feb 2022 — Apr 2024 [monthly]

    Terminated PHASE3

    Status: Suspended → Terminated

  5. Jan 2021 — Feb 2022 [monthly]

    Suspended PHASE3

▶ Show 7 earlier versions

  1. Sep 2020 — Jan 2021 [monthly]

    Suspended PHASE3

    Status: Recruiting → Suspended

  2. Dec 2018 — Sep 2020 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  3. Jun 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE3

  4. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

  5. Jun 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE3

    Phase: NA → PHASE3

  6. Feb 2017 — Jun 2017 [monthly]

    Not Yet Recruiting NA

  7. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mike O'Callaghan Military Hospital
Data source: Mike O'Callaghan Military Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations